ABOUT US

The Abigail Institute for Cancer Research was founded to support cancer research. We are pursuing a treatment for cancer by supporting scientific research and development activities across a broad range of organizations and professionals.

Cancer remains among the most significant health threats for humanity. According to the World Health Organization, cancer is the second leading cause of death globally and in 2015 there were 8.8 million cancer deaths worldwide. Nearly 1 in 6 deaths is due to cancer. The number of new cancer cases will rise to 22 million per year within the next two decades, compared to 14 million new cases in 2012. Worldwide, the economic impact of cancer is approximately $1.16 trillion dollars annually. According to the National Cancer Foundation, there were approximately 1.7 million new cancer diagnoses in 2016, with about 600,000 deaths from cancer that year.

THE Research TEAM

A group of scientists and doctors have come together to take a novel approach to treating cancers of all types. We have identified unique compounds that bind selectively to cancer cells. The idea is to combine these compounds with cancer-killing agents. The combination of compounds that target tumors, with other agents that either kill or disable the tumor, holds real promise for new ways to treat disease. We are currently partnered with cancer research professionals, working at The University of Colorado, Denver; The University of Colorado, Colorado Springs; MD Anderson Cancer Center; The University of Colorado, Boulder; and Georgia State University.

Three top scientists in cancer research serve on our Scientific Advisory Board. A team of physicists, chemists and biologists at The University of Colorado have been studying the effects of various drugs in tumor therapy for many years and have agreed to be on our team. We have developed two potential drugs that are currently being evaluated and studied at The University of Colorado in Colorado Springs.

This research has been ongoing, part time, for over four years. These efforts so far, have been funded. Now that the research has achieved a certain level of technical success, we have decided to form “Abigail” to bring on additional funds that will accelerate our efforts.

RESEARCH ACTIVITIES

The Abigail Institute for Cancer Research intends to fund research efforts at the above mentioned entities.

We will design, test and evaluate, new molecules with unique cancer fighting properties. Those molecules will then be exposed to tumor cells of various types at The University of Colorado, Denver and Colorado Springs. The tumor cells and molecules will be tested “in-vitro” (test tube) and “in-vivo” (animal). Abigail will fund the research efforts for specific projects related to this technology. A full description of the activities and research plan is available upon request.

FUNDING SOURCES

The Abigail Institute for Cancer Research will seek donations from both private individuals, Government organizations, as well as other non-profits.

The Abigail Institute for Cancer Research will be managed by an independent board of directors, consisting of medical and business professionals.

MANAGEMENT

INDIRECT COST RECOVERY

The Abigail Institute for Cancer Research policy: No “indirect cost recovery” (ICR) will be granted. All donated funds must be use for “direct costs” only.

Contact

OUR Namesake

Abigail Small was born in 2007. She lives in Fredericksburg, Virginia and has three sisters and a brother. She likes to sing and dance and loves her dogs. In 2017, at age 9, she told her mom that her “tummy hurt.” That was on a Tuesday and three days later she was diagnosed with a rare form of ovarian cancer. She completed six rounds of chemotherapy. If all goes well, she will need to see the doctor every six months for the rest of her life, to ensure that this fast-growing and lethal cancer doesn’t come back. She says she is grateful that she can take medicine that will kill her cancer and she laughs and plays a lot for a kid facing such a steep climb. The cancer consumed one of her ovaries. The treatment may have rendered her incapable of having children. Abigail's treatment has weakened her heart, lungs, and immune system. Though the cancer is currently undetectable in her little body, it could return at any time. Abigail’s parents are grateful for every day they have without cancer and even more grateful she is still around to enjoy those days. She is optimistic, strong and resilient. More of us should be like her. The Abigail Institute for Cancer Research is named in her honor. The world has too many kids like Abigail. This foundation hopes to help more of them and the countless others fighting cancer.

Please join us in this cause.